Clinical trials recruiting for Early Alzheimer's Disease
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| MK-2214 | 1 |
| TTYP01 tables 0mg | 1 |
| TTYP01 tables 60mg | 1 |
| TTYP01 tables 90mg | 1 |
| human Mesenchymal Stem Cells | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Florida | 2 |
| California | 1 |
| Connecticut | 1 |
| Georgia | 1 |
| Illinois | 1 |
| Massachusetts | 1 |
| Missouri | 1 |
| New Jersey | 1 |
| New York | 1 |
| North Carolina | 1 |
| Ohio | 1 |
| Pennsylvania | 1 |
Top cities
Self-screener
Recruiting trials
- A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- A Study to Evaluate the Efficacy and Safety of TTYP01 Tablets in Early Symptomatic Alzheimer's Disease
- Effect of Transcranial Alternating Current Stimulation(tACS) for Early Alzheimer's Disease
- Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's Disease.
Related conditions
Trials recruiting for Early Alzheimer's Disease often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Early Alzheimer's Disease trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.